These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34728558)

  • 1. Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study.
    Cheng JS; Hu JH; Chang MY; Lin MS; Ku HP; Chien RN; Chang ML
    J Psychiatry Neurosci; 2021; 46(6):E583-E591. PubMed ID: 34728558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between breast cancer and hepatitis C: A joint study of hospitalized patients and nationwide cohorts.
    Cheng JS; Chen TC; Chen TD; Ku HP; Huang SW; Wu TS; Chien RN; Chang ML
    Transl Res; 2022 Jul; 245():117-129. PubMed ID: 35259528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Hepatitis C Virus Infection and Esophageal Cancer: An Asian Nationwide Population-Based Cohort Study.
    Chu YY; Cheng JS; Wu TS; Chen CW; Chang MY; Ku HP; Chien RN; Chang ML
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34071668
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients.
    Hsu YC; Lin JT; Ho HJ; Kao YH; Huang YT; Hsiao NW; Wu MS; Liu YY; Wu CY
    Hepatology; 2014 Apr; 59(4):1293-302. PubMed ID: 24122848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan.
    Hsu YH; Hung PH; Muo CH; Tsai WC; Hsu CC; Kao CH
    Medicine (Baltimore); 2015 Nov; 94(47):e2113. PubMed ID: 26632730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: A population-based cohort study.
    Chen VC; Lu ML; Yang YH; Weng JC; Chang CC
    J Affect Disord; 2019 Jun; 253():147-153. PubMed ID: 31035215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C accelerates extrahepatic cholangiocarcinoma risk: a joint study of hospital-based cases and nationwide population-based cohorts in a viral hepatitis-endemic area.
    Huang SW; Cheng JS; Chen WT; Wu TS; Ku HP; Yeh CN; Chien RN; Chang ML
    Am J Cancer Res; 2023; 13(7):3080-3090. PubMed ID: 37559993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.
    Lin MS; Chen TH; Lin WY; Liu CH; Hsieh YY; Chiu WN; Chang CH; Chen MY; Chung CM; Lin YS
    BMC Gastroenterol; 2017 Aug; 17(1):99. PubMed ID: 28814273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Interferon-Based Therapy on Hepatitis C-Associated Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
    Cheng JS; Lin YS; Hu JH; Chang MY; Ku HP; Chien RN; Chang ML
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy reduces risk of haemorrhagic stroke in patients with HCV infection: a nationwide cohort study.
    Lin MS; Chung CM; Lin WY; Wei KL; Wang J; Lee YY; Hu JH; Tung TH; Lin YS
    Antivir Ther; 2018; 23(1):43-52. PubMed ID: 28471350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer.
    Su TH; Tseng TC; Liu CJ; Chou SW; Liu CH; Yang HC; Chen PJ; Chen DS; Chen CL; Kao JH
    Int J Cancer; 2020 Aug; 147(3):901-908. PubMed ID: 31853972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts.
    Chen CW; Cheng JS; Chen TD; Le PH; Ku HP; Chang ML
    Therap Adv Gastroenterol; 2019; 12():1756284819855732. PubMed ID: 31244896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Metabolic Associations of Hepatitis C With Colon and Rectal Cancers: A 9-Year Nationwide Population-Based Cohort Study.
    Chen CW; Shan Cheng J; Chen TH; Kuo CJ; Ku HP; Chien RN; Chang ML
    Clin Colorectal Cancer; 2024 Sep; ():. PubMed ID: 39341699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease.
    Chen YC; Hwang SJ; Li CY; Wu CP; Lin LC
    Medicine (Baltimore); 2015 Aug; 94(32):e1334. PubMed ID: 26266379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.
    Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
    Hepatology; 2016 Mar; 63(3):721-30. PubMed ID: 26662347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan.
    Chen YC; Chiou WY; Hung SK; Su YC; Hwang SJ
    BMC Nephrol; 2013 Sep; 14():187. PubMed ID: 24011024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.
    Lin SY; Lin CL; Ju SW; Wang IK; Lin CC; Lin CH; Hsu WH; Liang JA
    PLoS One; 2017; 12(3):e0173125. PubMed ID: 28264004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of New-Onset Atrial Fibrillation Among Asian Chronic Hepatitis C Virus Carriers: A Nationwide Population-Based Cohort Study.
    Yang YH; Chiang HJ; Yip HK; Chen KJ; Chiang JY; Lee MS; Sung PH
    J Am Heart Assoc; 2019 Nov; 8(22):e012914. PubMed ID: 31711382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.